• LAST PRICE
    1.0100
  • TODAY'S CHANGE (%)
    Trending Up0.0259 (2.6318%)
  • Bid / Lots
    1.0200/ 1
  • Ask / Lots
    1.0400/ 1
  • Open / Previous Close
    0.9900 / 0.9841
  • Day Range
    Low 0.9800
    High 1.0124
  • 52 Week Range
    Low 0.8531
    High 3.3994
  • Volume
    295,328
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.9841
TimeVolumeIRD
09:32 ET16840.99
09:35 ET5100.9899
09:44 ET19000.985
09:46 ET5000.984201
09:51 ET14070.9899
09:53 ET1000.989174
10:02 ET4850.989114
10:08 ET4240.98995
10:11 ET46540.9909
10:13 ET29000.995
10:24 ET1250.991
10:31 ET12000.9955
10:33 ET92581
10:36 ET16001
10:40 ET147001
10:44 ET2000.9999
10:47 ET60000.99995
10:49 ET220891
10:54 ET1660.9999
10:58 ET3500.9999
11:00 ET33001
11:09 ET2501.0124
11:12 ET20001
11:14 ET11001
11:16 ET10001
11:20 ET6411
11:23 ET98261
11:27 ET14431
11:34 ET8000.9999
11:41 ET3000.9999
11:43 ET67150.9999
11:48 ET4971
11:50 ET13040.99995
11:56 ET1000.999999
11:57 ET1081
11:59 ET1000.9999
12:01 ET9000.9999
12:03 ET7810.9999
12:10 ET15000.999884
12:15 ET24000.9999
12:17 ET1000.9998
12:21 ET31000.9998
12:28 ET35830.99985
12:30 ET11800.9998
12:35 ET39560.9999
12:37 ET10070.9999
12:44 ET1000.999449
12:46 ET2000.999
12:51 ET1000.991
12:53 ET4860.9999
01:06 ET4000.991
01:13 ET25000.9928
01:15 ET19000.9911
01:20 ET4000.9911
01:22 ET13470.99095
01:24 ET3000.9911
01:29 ET1000.99325
01:31 ET45390.9901
01:33 ET9350.9897
01:40 ET3000.9876
01:49 ET1250.985518
01:51 ET23720.9876
01:54 ET6880.985
01:58 ET1000.9839
02:07 ET37000.9827
02:09 ET3000.9851
02:12 ET5050.9852
02:18 ET24000.9905
02:20 ET1000.98
02:21 ET2250.9934
02:27 ET3270.98
02:34 ET1000.98
02:48 ET1000.98
02:50 ET1000.9935
02:57 ET1000.994
03:10 ET5500.9914
03:12 ET18000.9999
03:15 ET13330.9914
03:17 ET25540.9918
03:21 ET5000.9922
03:24 ET59750.9932
03:28 ET2000.9996
03:32 ET4000.98
03:33 ET39000.9882
03:37 ET5070.986299
03:39 ET1000.98
03:42 ET53550.9863
03:44 ET38270.986299
03:46 ET43140.9825
03:48 ET22540.9999
03:50 ET164741
03:51 ET42401
03:53 ET159311.01
03:55 ET36401.01
03:57 ET522821.01
04:00 ET99231.01
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIRD
Opus Genetics Inc
30.9M
-0.9x
---
United StatesICCC
ImmuCell Corp
32.6M
-7.6x
---
United StatesEVFM
Evofem Biosciences Inc
1.0M
0.0x
---
United StatesCVSI
CV Sciences Inc
8.2M
-2.5x
-25.43%
United StatesETST
Earth Science Tech Inc
39.8M
23.7x
---
United StatesCYAN
Cyanotech Corp
2.6M
-0.5x
---
As of 2024-11-23

Company Information

Opus Genetics, Inc., formerly Ocuphire Pharma, Inc., is a clinical-stage ophthalmic biopharmaceutical company. The Company is engaged in developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. Its pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. Its most advanced gene therapy program is designed to address mutations in the LCA5 gene, which encodes the lebercilin protein and being evaluated in a Phase I/II open-label, dose-escalation trial, with advancing early data. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Contact Information

Headquarters
37000 Grand River Ave., Suite 120FARMINGTON HILLS, MI, United States 48335
Phone
248-681-9815
Fax
240-268-5310

Executives

Independent Chairman of the Board
Cam Gallagher
President, Director
Benjamin Yerxa
Chief Executive Officer, Director
George Magrath
Chief Financial Officer, Principal Financial Officer
Nirav Jhaveri
Chief Operating Officer
Joseph Schachle

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$30.9M
Revenue (TTM)
$8.4M
Shares Outstanding
31.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.18
EPS
$-1.09
Book Value
$2.08
P/E Ratio
-0.9x
Price/Sales (TTM)
3.7
Price/Cash Flow (TTM)
---
Operating Margin
-351.68%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.